首页> 外国专利> RECOMBINANT PROTEIN PRODUCED FROM PSEUDOMONAS AERUGINOSA-DERIVED CHOLINESTERASE GENE, AND COMPOSITION INCLUDING RECOMBINANT PROTEIN AS ACTIVE INGREDIENT FOR PREVENTING AND TREATING ORGANOPHOSPHOROUS OR CARBAMATE-BASED NERVE AGENT TOXICOSIS OR NERVOUS SYSTEM DISEASES CAUSED BY CHOLINE EFFECT

RECOMBINANT PROTEIN PRODUCED FROM PSEUDOMONAS AERUGINOSA-DERIVED CHOLINESTERASE GENE, AND COMPOSITION INCLUDING RECOMBINANT PROTEIN AS ACTIVE INGREDIENT FOR PREVENTING AND TREATING ORGANOPHOSPHOROUS OR CARBAMATE-BASED NERVE AGENT TOXICOSIS OR NERVOUS SYSTEM DISEASES CAUSED BY CHOLINE EFFECT

机译:由铜绿假单胞菌衍生的胆碱酯酶基因生产的重组蛋白,以及包含重组蛋白的有效成分,用于预防和治疗因疾病或神经系统疾病而引起的有机磷或氨基甲酸酯引起的神经性毒剂或神经系统疾病

摘要

The present invention relates to: a recombinant protein (SEQ ID NO: 1) produced from a cholinesterase gene (SEQ ID NO: 2) derived from Pseudomonas aeruginosa, wherein the recombinant protein is not inhibited by an organophosphorous or carbamate-based nerve agent and maintains an ACHE activity; and a composition including the recombinant protein as an active ingredient for preventing and treating organophosphorus or carbamate-based nerve agent toxicosis or nervous system diseases caused by a choline effect. The composition can be used as a pharmaceutical composition for preventing and treating nervous system diseases, a health functional food, and a health supplement food.;COPYRIGHT KIPO 2020
机译:本发明涉及:由源自铜绿假单胞菌的胆碱酯酶基因(SEQ ID NO:2)产生的重组蛋白(SEQ ID NO:1),其中该重组蛋白不受有机磷或氨基甲酸酯基神经毒剂的抑制,并且维持ACHE活动;组合物,其包含重组蛋白作为有效成分,用于预防和治疗胆碱效应引起的有机磷或氨基甲酸酯类神经毒症或神经系统疾病。该组合物可用作预防和治疗神经系统疾病的药物组合物,保健功能食品和保健食品。; COPYRIGHT KIPO 2020

著录项

  • 公开/公告号KR102100633B1

    专利类型

  • 公开/公告日2020-04-14

    原文格式PDF

  • 申请/专利权人 JILGYUNGYI CO. LTD.;

    申请/专利号KR20190087620

  • 申请日2019-07-19

  • 分类号C07K14/21;A23L33/195;A61K38;A61P25/30;

  • 国家 KR

  • 入库时间 2022-08-21 11:04:52

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号